Effect of deserpidine and pargyline on the levels of biogenic amines in brain, liver and heart of mice.
D000818:Animals; D001679:Biogenic Amines / Q000032:analysis* / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects*; D004298:Dopamine / Q000032:analysis / Q000378:metabolism; D006321:Heart / Q000187:drug effects; D008099:Liver / Q000032:analysis* / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009206:Myocardium / Q000032:analysis* / Q000378:metabolism; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism; D009928:Organ Specificity; D010293:Pargyline / Q000494:pharmacology*; D012110:Reserpine / Q000031:analogs & derivatives / Q000494:pharmacology; D046948:Secologanin Tryptamine Alkaloids / Q000494:pharmacology*; D012701:Serotonin / Q000032:analysis / Q000378:metabolism; D013154:Spleen / Q000032:analysis / Q000378:metabolism
D001679:Biogenic Amines; D046948:Secologanin Tryptamine Alkaloids; D012701:Serotonin; D012110:Reserpine; D010293:Pargyline; D004298:Dopamine; D009638:Norepinephrine